SUN Pharmaceutical Industries Limited Fexofenadine Export Data — India (DGFT 2022–2026)

Name: SUN Pharmaceutical Industries Limited Fexofenadine Export Records India — #5 Exporter, 154 Shipments, $7.7M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Fexofenadine

India Pharmaceutical Trade Intelligence

$109.6M224 Suppliers97 CountriesHS 30049039

ExportsIndia → UNITED KINGDOM30.8%India → UNITED STATES26.9%

ImportsSINGAPORE → India$150.2K BRAZIL → India$14.3K

#1 Supplier: GRANULES INDIA

SUN Pharmaceutical Industries Limited — Fexofenadine Exporter #5 | $7.7M Trade Value | TransData Nexus | TransData Nexus

SUN Pharmaceutical Industries Limited — Fexofenadine Exporter Profile

Indian Pharmaceutical Exporter · #5 for Fexofenadine · $7.7M export value · DGFT Verified

SUN Pharmaceutical Industries Limited is the #5 Indian exporter of Fexofenadine with $7.7M in export value and 154 verified shipments. SUN Pharmaceutical Industries Limited holds a 7.0% market share in Fexofenadine exports across 7 countries. The company exports 118 pharmaceutical products worth $979.8M across 25 therapeutic categories.

SUN Pharmaceutical Industries Limited — Fexofenadine Export Profile: Buyers & Destinations

SUN Pharmaceutical Industries Limited Fexofenadine export treemap — buyers and destination countries | TransData Nexus

Where Does SUN Pharmaceutical Industries Limited Export Fexofenadine?

Country	Value	Shipments	Share
UNITED STATES	$2.2M	81	44.4%
BRAZIL	$1.5M	46	30.4%
RUSSIA	$848.3K	17	16.8%
SOUTH AFRICA	$289.9K	10	5.7%

Who Are the Top Buyers of Fexofenadine from SUN Pharmaceutical Industries Limited?

Buyer	Country	Value	Orders
OHM LABORATORIES INC.	UNITED STATES	$1.4M	55
OHM LABORATORIES INC	UNITED STATES	$832.3K	24
AO RANBAXY	RUSSIA	$498.3K	10
M/S. RANBAXY FARMACEUTICA LTDA.	BRAZIL	$450.0K	9
AO "RANBAXY"	RUSSIA	$250.0K	5
M/S. RANBAXY FARMACEUTICA LTDA :	BRAZIL	$249.6K	10
M S RANBAXY FARMACEUTICA LTDA	BRAZIL	$172.4K	6
RANBAXY FARMACEUTICA LTDA	BRAZIL	$150.0K	3
RANBAXYFARMACEUTICA LTDA.	BRAZIL	$100.0K	2
MS RANBAXY FARMACEUTICA LIMITED	BRAZIL	$100.0K	2

SUN Pharmaceutical Industries Limited supplies Fexofenadine to 27 buyers globally. The largest buyer is OHM LABORATORIES INC. (UNITED STATES), followed by OHM LABORATORIES INC (UNITED STATES) and AO RANBAXY (RUSSIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Fexofenadine Formulations Does SUN Pharmaceutical Industries Limited Export?

Product Description / Formulation	Value	Shipments
FEXOFENADINE HYDROCHLORIDE TABLETS USP 1	$415.1K	14
FEXOFENADINE HYDROCHLORIDE 60MG AND PSEU	$200.0K	4
FEXOFENADINE 180MG TABS 150CT - OHM PACK	$200.0K	4
FEXOFENADINE TAB 120 MG PACK: 10s Strip	$200.0K	4
FEXOFENADINE TAB 120MG PACK: 10s Strip B	$150.0K	3
FEXOFENADINE TAB 180 MG PACK: 10s Strip	$150.0K	3
FEXOFENADINE HYDROCHLORIDE TABLETS USP 180MG 150CT PACK : BT 150 T/C (BATCH NO AS PER INVOICE)	$150.0K	3
FEXADIN TAB 180 MG EACH TABLETS CONTAINSFEXOFENADINE HYDRCHLORIDE EQUIVALENT TO180 MG PACK: 10S STRIP	$150.0K	3
FEXADIN TAB 120MG PACK:10S STRIP BATCH:DFF1617A EACH TAB CONTS. FEXOFENADINE HCLEQ TO 120MG	$148.3K	3
FEXOFENADINE TAB 120 MG EACH TABLET CONT	$100.0K	2

SUN Pharmaceutical Industries Limited exports 103 distinct Fexofenadine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is FEXOFENADINE HYDROCHLORIDE TABLETS USP 1 with 14 shipments worth $415.1K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Fexofenadine Exporters?

Exporters ranked immediately above and below #5 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
4	DR.REDDY'S LABORATORIES LTD	$12.4M	249	5	$50.0K
1	GRANULES INDIA LIMITED	$9.7M	194	1	$50.0K
5	SUN PHARMACEUTICAL INDUSTRIES LIMITED ★	$7.7M	154	7	$50.0K
7	MEDREICH LIMITED	$5.7M	163	6	$34.8K
8	LYRUS LIFE SCIENCES PRIVATE LIMITED	$3.4M	68	1	$50.0K

SUN Pharmaceutical Industries Limited ranks #5 among 224 Indian Fexofenadine exporters. Average shipment value of $50.0K compared to the market average of $365.5K. The closest competitors by value are DR.REDDY'S LABORATORIES LTD and GRANULES INDIA LIMITED.

Which Indian Ports Ship Fexofenadine Exports?

Port	Shipments	% Share
SAHAR AIR	569	13.4%
JNPT/ NHAVA SHEVA SEA	385	9.1%
SAHAR AIR CARGO ACC (INBOM4)	362	8.5%
NHAVA SHEVA SEA (INNSA1)	350	8.3%
HYDERABAD ICD	229	5.4%
CHAWAPAYAL ICD	186	4.4%
JNPT	161	3.8%
CHAWAPAYAL ICD (INCPR6)	142	3.4%

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Fexofenadine Exports

Sun Pharma's export operations, valued at $979.8 million, are significantly influenced by current geopolitical events. The ongoing Israel-Iran tensions have led to disruptions in the Red Sea shipping routes, a critical corridor for Indian pharmaceutical exports to Europe and North Africa. Major shipping lines have imposed 'Emergency Risk Surcharges,' increasing freight costs and extending transit times by 10–15 days. These delays pose risks to the integrity of time-sensitive and temperature-controlled pharmaceutical shipments. (pharmaceuticalcommerce.com)

In the United States, policy shifts towards domestic manufacturing and the imposition of tariffs on imported pharmaceuticals have created challenges for Indian exporters. Sun Pharma, which supplies a substantial portion of generics to the U.S. market, faces potential reductions in export volumes due to these protectionist measures. The company is exploring strategies such as establishing local partnerships and investing in U.S.-based manufacturing to mitigate these impacts. (odrindia.in)

The European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) introduces additional compliance requirements for exporters. Sun Pharma must adapt to these regulations to maintain its market presence in the EU, necessitating investments in sustainable manufacturing practices and comprehensive reporting mechanisms. (sgeexport.com)

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains a critical focus for Sun Pharma. The company has encountered challenges with the U.S. FDA, including import alerts and non-compliance letters for certain facilities. Addressing these issues involves implementing corrective actions and awaiting reinspection to resume full operations. (business-standard.com)

Globally, the pharmaceutical industry faces increasing scrutiny regarding quality standards. Sun Pharma's commitment to adhering to Good Manufacturing Practices (GMP) and other regulatory requirements is essential to maintain its export licenses and market reputation. Continuous investment in quality control systems and compliance infrastructure is imperative to navigate the evolving regulatory landscape.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Fexofenadine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: SUN Pharmaceutical Industries Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 160 individual customs records matching SUN Pharmaceutical Industries Limited exporting Fexofenadine, covering 103 formulations to 7 countries via 27 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 97+ countries, 599+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Fexofenadine

Fexofenadine

SUN Pharmaceutical Industries Limited — Fexofenadine Exporter Profile

SUN Pharmaceutical Industries Limited — Fexofenadine Export Profile: Buyers & Destinations

Where Does SUN Pharmaceutical Industries Limited Export Fexofenadine?

Who Are the Top Buyers of Fexofenadine from SUN Pharmaceutical Industries Limited?

What Is India's Total Fexofenadine Export Value and How Much Does SUN Pharmaceutical Industries Limited Contribute?

What Is the Average Shipment Value for SUN Pharmaceutical Industries Limited's Fexofenadine Exports?

How Does SUN Pharmaceutical Industries Limited Compare to Other Indian Fexofenadine Exporters?

What Fexofenadine Formulations Does SUN Pharmaceutical Industries Limited Export?

Regulatory Requirements: Exporting Fexofenadine to Key Markets

United States — FDA

Brazil — ANVISA

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Fexofenadine Exporters?

Which Indian Ports Ship Fexofenadine Exports?

Fexofenadine — Export Intelligence Video

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Fexofenadine Exports

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

About SUN Pharmaceutical Industries Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Fexofenadine Export Data from SUN Pharmaceutical Industries Limited

Fexofenadine Stats

Company Overview

Top Products by SUN Pharmaceutical Industries Limited

Related Analysis

Need Detailed Export Data?

Data Source